21
Last reporting period 30 Jun, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.196
Exchange
XHKG - Hong Kong Exchange
-0.14 B
Last period CFO ,CNY
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also CARsgen Therapeutics
Company Analysis
2171.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2171.HK financial analysis by Eyestock methodology
Valuation
2171.HK valuation using historical relative method
Statements
2171.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2171.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
CARsgen Therapeutics`s CFO for the period ended 2023-06-30 is -0.14 B CNY
